New warning about risk for Guillain-Barré syndrome after Shingrix administration US Food and Drug Administration requires warning about GBS be added to the prescribing information for Shingrix (herpes zoster vaccine) Five-day treatment effective for community-acquired pneumonia in childrenCanadian study finds 5-day high-dose amoxicillin therapy comparable to standard 10 days in children with CAP not requiring hospitalization. How well do current COVID-19 vaccines protect against COVID-19 variants? A look at what is currently known and unknown about vaccine efficacy against COVID-19 variants of concern. Be alert for possible delayed local reactions with Moderna COVID-19 vaccine RCT shows no benefit from ivermectin for patients with mild COVID-19: Shigella outbreak in Vancouver's Downtown Eastside 'a disease of destitution' Patients recovered from COVID-19 might need only single dose of mRNA vaccine Exploratory study suggests immune responses in patients previously infected with SARS-CoV2 is not boosted further by a second dose of vaccine. Canadian-made DNA Covid-19 vaccine going to trial Spotlight on COVID-19 variants Alternate storage temperatures approved for Pfizer-BioNTech COVID-19 vaccine Health Canada approves more flexible storage requirements for frozen vials and transportation conditions for thawed undiluted vials First Previous 53 54 55 56 57 Next Last
